Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation

被引:4
作者
Baek, Sung Uk [1 ]
Park, Min Seon [1 ]
Cho, Bum-Joo [1 ]
Park, In Won [1 ]
Kwon, Soonil [1 ]
机构
[1] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Ophthalmol, 22 Gwanpyeong Ro,170beon Gil, Anyang 14068, South Korea
基金
新加坡国家研究基金会;
关键词
MEAN PLATELET VOLUME; RANIBIZUMAB; METAANALYSIS; SEVERITY; THERAPY; MARKER;
D O I
10.1038/s41598-021-93384-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Uncontrolled diabetes has been associated with progression of diabetic retinopathy (DR) in several studies. Therefore, we aimed to investigate systemic and ophthalmic factors related to worsening of DR even after completion of panretinal photocoagulation (PRP). We retrospectively reviewed DR patients who had completed PRP in at least one eye with a 3-year follow-up. A total of 243 eyes of 243 subjects (mean age 52.6 +/- 11.6 years) were enrolled. Among them, 52 patients (21.4%) showed progression of DR after PRP (progression group), and the other 191 (78.6%) patients had stable DR (non-progression group). The progression group had higher proportion of proliferative DR (P=0.019); lower baseline visual acuity (P<0.001); and higher platelet count (P=0.048), hemoglobin (P=0.044), and hematocrit, (P=0.042) than the non-progression group. In the multivariate logistic regression analysis for progression of DR, baseline visual acuity (HR: 0.053, P<0.001) and platelet count (HR: 1.215, P=0.031) were identified as risk factors for progression. Consequently, we propose that patients with low visual acuity or high platelet count are more likely to have progressive DR despite PRP and require careful observation. Also, the evaluation of hemorheological factors including platelet counts before PRP can be considered useful in predicting the prognosis of DR.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation
    Schmidinger, Gerald
    Maar, Noemi
    Bolz, Matthias
    Scholda, Christoph
    Schmidt-Erfurth, Ursula
    ACTA OPHTHALMOLOGICA, 2011, 89 (01) : 76 - 81
  • [32] Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy
    Zhang, Quan
    Zhang, Ting
    Zhuang, Hong
    Sun, Zhongcui
    Qin, Yaowu
    OPHTHALMOLOGICA, 2019, 242 (02) : 59 - 68
  • [33] Results of a Randomized Clinical Trial of Aflibercept vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Is It Time to Retire Your Laser?
    Glassman, Adam R.
    JAMA OPHTHALMOLOGY, 2017, 135 (07) : 685 - 686
  • [34] Retinal and Choroidal Alterations in Diabetic Retinopathy Treatment using Subthreshold Panretinal Photocoagulation with Endpoint Management Algorithm: A Secondary Analysis of a Randomized Clinical Trial
    Li, Zijing
    Lu, Tu
    Zhou, Lijun
    Huang, Chuangxin
    Zhao, Hongkun
    Liang, Jiandong
    Li, Cong
    Cong, Qifeng
    Lan, Yuqing
    Jin, Chenjin
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 1867 - 1880
  • [35] Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy A Systematic Review and Meta-Analysis
    Macaron, Marie-Michele
    Al Sabbakh, Nader
    Shami, M. Zaid
    Akrobetu, Dennis
    Bourdakos, Natalie E.
    Abdulsalam, Fatma A. M.
    Nakanishi, Hayato
    Than, Christian A.
    Bakri, Sophie J.
    OPHTHALMOLOGY RETINA, 2025, 9 (02): : 105 - 121
  • [36] Clinical efficacy of intravitreal aflibercept injection versus vitrectomy with panretinal photocoagulation for patients with proliferative diabetic retinopathy A protocol for systematic review and meta-analysis
    Hu, Yao
    Shen, Jinxia
    Peng, Yi
    MEDICINE, 2021, 100 (14) : E25354
  • [37] Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis
    Fallico, Matteo
    Maugeri, Andrea
    Lotery, Andrew
    Longo, Antonio
    Bonfiglio, Vincenza
    Russo, Andrea
    Avitabile, Teresio
    Pulvirenti, Alfredo
    Furino, Claudio
    Cennamo, Gilda
    Barchitta, Martina
    Agodi, Antonella
    Reibaldi, Michele
    ACTA OPHTHALMOLOGICA, 2021, 99 (06) : E795 - E805
  • [38] Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
    Gunasekaran, Thiruvarasu, Jr.
    Gunasekaran, Yuarrani
    Hui, Pua Tze
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [39] Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis
    Yates, William B.
    Mammo, Zaid
    Simunovic, Matthew P.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (06): : 355 - 363
  • [40] Optical coherence tomography angiography reveals progressive worsening of retinal vascular geometry in diabetic retinopathy and improved geometry after panretinal photocoagulation
    Fayed, Alaa E.
    Abdelbaki, Ahmed M.
    El Zawahry, Omar M.
    Fawzi, Amani A.
    PLOS ONE, 2019, 14 (12):